Congress releases Jack Smith testimony on Trump prosecutions
Congress has released Jack Smith’s testimony defending his Trump prosecutions, detailing evidence claims and warning of potential political retribution.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Congress has released Jack Smith’s testimony defending his Trump prosecutions, detailing evidence claims and warning of potential political retribution.
Trump Media plans to issue a new cryptocurrency to shareholders via Crypto.com, deepening the Trump family’s push into digital assets amid ongoing market volatility.
A US investment bank upgraded TeraWulf shares after lifting its price target, citing strong growth potential from a shift toward high-performance computing alongside Bitcoin mining.
Several crypto billionaires suffered heavy losses in 2025 after an October market slide, even as a small number of industry figures posted strong gains.
Bitcoin could see strong price momentum in 2026 as expected US liquidity injections support risk assets, even as analysts warn that political and macroeconomic uncertainty may limit gains.
Matthews International Corporation (NASDAQ:MATW) officially closed the sale of its Warehouse Automation business to Duravant on Wednesday, December 31, 2025.
The deal, first announced in mid-November, provides the Pittsburgh-based firm with $232.1 million in total consideration, including $225.4 million in cash.
Mitsubishi UFJ Financial Group (NYSE:MUFG) has elected Carolyn DuChene to the Board of Directors of MUFG Americas Holdings Corporation and the MUFG U.S. Advisory Board, effective January 1, 2026.
Ondas Holdings (NASDAQ:ONDS) closed out a transformational fiscal year on Wednesday, announcing approximately $10 million in new purchase orders for its autonomous systems portfolio.
DigitalBridge (NYSE:DBRG) and Crestview Partners have completed their $1.5 billion take-private acquisition of WideOpenWest (WOW!), concluding the transaction on December 31, 2025.
FibroBiologics (NASDAQ:FBLG) took a decisive step toward clinical-stage operations on Wednesday, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to begin Phase 1/2 trials for its lead psoriasis candidate, CYPS317.
SOL Strategies (NASDAQ: STKE) reported full-year financial results for the fiscal year ended September 30, 2025, posting revenue of CAD$14.5 million, a 36.7% increase year over year, driven primarily by the expansion of its staking and validator operations within the Solana ecosystem.
TransDigm Group (NYSE:TDG) has entered into a definitive agreement to acquire Stellant Systems for approximately $960 million in cash, marking a significant expansion of its highly engineered aerospace and defense component portfolio.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade